ClinConnect ClinConnect Logo
Search / Trial NCT04942041

Establishing Mechanical Thrombectomy at a Limited-volume Stroke Center - Effects on Patient Morbidity and Mortality

Launched by SORLANDET HOSPITAL HF · Jun 18, 2021

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

Stroke Thrombectomy Simulation Quality Program

ClinConnect Summary

This clinical trial is studying the effects of a medical procedure called mechanical thrombectomy on patients with a type of stroke known as acute ischemic stroke, which happens when a blood clot blocks a major blood vessel in the brain. The trial is taking place at Sørlandet Hospital in Norway, a facility that typically handles fewer stroke cases. To ensure the procedure is done safely and effectively, the hospital will use a special training program that simulates real-life situations. Researchers will closely watch how quickly patients receive treatment and track their recovery, including any complications that may arise.

To participate in this trial, you must be an adult experiencing a large vessel occlusion stroke, but you cannot have certain conditions like bleeding in the brain or other brain abnormalities. The study is currently recruiting participants aged between 18 and 80. If you or a family member are eligible and choose to join, you can expect to receive the thrombectomy procedure, and your progress will be monitored by the medical team to ensure the best outcomes.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients
  • Large vessel occlusion stroke
  • Exclusion Criteria:
  • Intracranial hemorrhage, tumor, aneurism or vascular malformation i the stroke area
  • More than 24 hours after stroke onset

About Sorlandet Hospital Hf

Sørlandet Hospital HF is a leading healthcare institution in Norway dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, the hospital focuses on innovative healthcare solutions that enhance patient outcomes and contribute to the medical knowledge base. With a commitment to ethical standards and regulatory compliance, Sørlandet Hospital HF collaborates with a diverse range of partners to conduct rigorous studies across various therapeutic areas, ensuring that research findings are both scientifically robust and clinically relevant. The institution's multidisciplinary approach fosters an environment of excellence in patient care and research, positioning it as a key player in the Norwegian healthcare landscape.

Locations

Kristiansand, Agder, Norway

Patients applied

0 patients applied

Trial Officials

Per Kristian Hyldmo, MD PhD

Principal Investigator

University of Stavanger, Norway

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials